Comparative effects of rifabutin and rifampicin on cytochromes P450 and UDP-glucuronosyl-transferases expression in fresh and cryopreserved human hepatocytes

Chemico-Biological Interactions

Volumn 121, Issue 1, 1999, Pages 37-48

  Reinach, Benedetta ^a   De Sousa, Georges ^b   Dostert, Philippe ^a   Ings, Robert ^a   Gugenheim, Jean ^c   Rahmani, Roger ^b  

^a PFIZER INC   (United States)

^b INSERM   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Cytochrome P450; Enzyme induction; Hepatocytes; Human; Rifabutin; Rifampicin

Indexed keywords

CYTOCHROME P450 ISOENZYME; DIAZEPAM; ETHOXYRESORUFIN; GLUCURONOSYLTRANSFERASE; MIDAZOLAM; RIFABUTIN; RIFAMPICIN; TESTOSTERONE; ZIDOVUDINE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CRYOPRESERVATION; CYTOTOXICITY; DOSE RESPONSE; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; LIVER METABOLISM;

EID: 0033006714     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(99)00089-7     Document Type: Article

References (26)

1. Strolin Benedetti M., Dostert P. Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies. Environ. Health Perspec. 102:1994;101-105.
2. Strolin Benedetti M. Inducing properties of Rifabutin and effects on the pharmacokinetics and metabolism of concomitant drugs. Pharmaceutical Res. 32:1995;177-187.
3. Waxman D.J., Lapenson D.P., Aoyama T., Gelboin H.V., Gonzalez F.J., Korzekwa K. Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch. Bichem. Biophys. 290:1991;160-166.
4. Fabre G., Rahmani R., Placidi M., Combalbert J., Covo J., Cano J.P., Coulange C., Ducros M., Rampal M. Characterization of midazolam metabolism using human hepatic microsomal fractions and hepatocytes in suspension obtained by perfusing whole human livers. Biochem. Pharmacol. 37:1988;4389-4397.
5. Kronbach T., Mathys D., Umeno M., Gonzalez F.J., Meyer U.A. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Mol. Pharmacol. 36:1989;89-96.
6. Thummel K.E., Shen D.D., Podoll T.D., Kunze K.L., Trager W.F., Hartwell P.S., Raisys V.A., Marsh C.L., McVicar J.P., Barr D.M., Perkins J.D., Carithers Jr R.L. Use of midazolam as a human cytochrome P450 3A probe: I. In vitro -in vivo correlations in liver transplant patients. J. Pharm. Exp. Ther. 271:1994;549-556.
7. Thummel K.E., Shen D.D., Podoll T.D., Kunze K.L., Trager W.F., Bacchi C.E., Marsh C.L., McVicar J.P., Barr D.M., Perkins J.D., Carithers Jr R.L. Use of Midazolam as a human cytochrome P4503A probe: II Characterization of inter- and intra-individual hepatic CYP3A variability after liver transplantation. J. Pharm. Exp. Ther. 271:1994;557-566.
8. Yasumori T., Nagata K., Yang S.K., Chen L.S., Murayama N., Yamazoe Y., Kato R. Cytochrome P450 mediated metabolism of diazepam in human and rat: involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner. Pharmacogenetics. 3:1993;291-301.
9. Andersson T., Miners J.O., Veronese M.E., Birkett D.J. Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms. Br. J. Clin. Pharmacol. 38:1994;131-137.
10. Daujat M., Pichard L., Fabre I., Pineau T., Fabre G., Bonfils C., Maurel P. Induction protocols for cytochromes P450IIIA in vivo and in primary cultures of animal and human hepatocytes. Methods in Enzymol. 206:1991;345-353.
11. Gillum J.G., Israel D.S., Polk R.E. Pharmacokinetic drug interactions with antimicrobial agents. Clin. Pharmakinet. 25:1993;450-482.
12. Gonzalez F.J. Molecular genetics of the P-450 superfamily. Pharmacol. Ther. 45:1990;1-38.
13. Rajaonarison J.F., Lacarelle B., de Sousa G., Catalin J., Rahmani R. In vitro glucuronidation of 3′-azido-3′-deoxythymidine by human liver: role of UDP-glucuronosyltransferase 2 form. Drug Metab. Dispos. 19:1991;809-815.
14. Nicolas F., de Sousa G., Thomas P., Placidi M., Lorenzon G., Rahmani R. Comparative metabolism of AZT in cultured hepatocytes from rats, dogs, monkeys and mans. Drug Metab. Dispos. 23:1994;308-313.
15. Rahmani R., Richard B., Fabre G., Cano J.P. Extrapolation of preclinical pharmacokinetics data to therapeutic drug use. Xenobiotica. 18:1988;71-88.
16. Dou M., de Sousa G., Lacarelle B., Placidi M., Lechene de la Porte P., Domingo M., Lafont H., Rahmani R. Thawed human hepatocytes in primary culture. Cryobiology. 29:1992;454-469.
17. Rahmani R., de Sousa G., Marre F., Nicolas F., Placidi M. Potential of freshly isolated and cryopreserved human hepatocytes in drug research and development. Rogiers V., Sonk W., Shepard E., Vercruysse A. Human cells in vitro pharmaco-toxicology-present status with Europe. 1993;117-138 VUB Press, Brussels.
18. Strolin Benedetti M., Efthymiopoulos C., Sassella D., Moro E., Repetto M. Autoinduction of rifabutin metabolism in man. Xenobiotica. 20:1990;1113-1119.
19. Breda M., Pianezzola E., Strolin Benedetti M., Efthymiopoulos C., Carpentieri M., Sassella D., Rimoldi R. A study of the effects of rifabutin on isoniazid pharmacokinetics and metabolism in healthy volunteers. Drug Metab. Drug Inter. 10:1992;323-340.
20. Borenfreund E., Puerner J.A. Toxicity determined in vitro by morphological alteration and netral red absorption. Tox. Lett. 24:1985;119-123.
21. Oesch F., Wagner H., Platt K.L., Arand M. Improved sample preparation for the testosterone hydroxylation assay using disposable extraction columns. J. Chrom. 582:1992;232-235.
22. Rutten A.A., Falke H.E., Catsburg J.F., Wortelboer H.M., Blaauboer B.J., Doorn L., van Leeuwen F.X., Theelen R., Rietjens IM. Interlaboratory comparison of microsomal ethoxyresorufin and pentoxyresorufin O-dealkylation determinations: standardization of assay conditions. Arch. Toxicol. 66:1992;237-244.
23. de Sousa G., Dou M., Lacarelle B., Placidi M., Rahmani R. Freshly isolated or cryopreserved human hepatocytes in primary culture: influence of drug metabolism of hepatotoxicity. Toxic. in Vitro. 5:1991;483-486.
24. Donato M.T., Castell J.V., Goméz-Lechon M.J. Effect of model inducers on cytochrome P450 activities of human hepatocytes in primary culture. Drug Metab. Dispos. 23:1995;553-558.
25. Li A.P., Maurel P., Gomez-Lechon M.J., Cheng L.C., Jurima-Romet M. Preclinical evaluation of drug-drug interaction potential: present status of application of primary human hepatocytes in the evaluation of cytochrome P450 induction. Chem. Biol. Interact. 107:1997;5-16.
26. Li A.P., Reith M.K, Rasmussen A., Gorski J.C., Hall S.D., Xu L., Kaminski D.L., Cheng L.K. Primary human hepatocytes as a tool for the evaluation of structure-activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine, and rifabutin. Chem. Biol. Interact. 107:1997;17-30.